SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-027457
Filing Date
2021-11-08
Accepted
2021-11-08 08:00:39
Documents
14
Period of Report
2021-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38629
2 ex99-1.htm EX-99.1 116784
3 ex99-1_001.gif GRAPHIC 2397
  Complete submission text file 0001493152-21-027457.txt   344219

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE vbiv-20211108.xsd EX-101.SCH 3034
5 XBRL LABEL FILE vbiv-20211108_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE vbiv-20211108_pre.xml EX-101.PRE 22365
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3629
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 211386560
SIC: 2834 Pharmaceutical Preparations